COVID-19 treatment Archives | Be Korea-savvy
S. Korea OKs Celltrion’s COVID-19 Treatment for Conditional Use

S. Korea OKs Celltrion’s COVID-19 Treatment for Conditional Use

SEOUL, Feb. 5 (Korea Bizwire) — South Korea’s drug safety agency said Friday it has approved pharmaceutical giant Celltrion Inc.’s COVID-19 treatment candidate on several conditions. The conditional marketing authorization of CT-P59, an anti-COVID-19 monoclonal antibody treatment candidate, marks the country’s first homegrown COVID-19 treatment. The Korean Ministry of Food and Drug Safety said CT-P59 [...]

Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results for COVID-19 Treatment Candidate Based on Its MyCell Technology™

Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results for COVID-19 Treatment Candidate Based on Its MyCell Technology™

TORONTO, Jan. 14 (Korea Bizwire) — Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2), a developer of MedTech innovation, and Glow LifeTech Ltd. (“Glow”), a private company in which Relay holds a significant equity interest, are pleased to report on developments related to Glow’s MyCell Technology™ (“MyCell”). Glow LifeTech partner [...]

Celltrion Says its COVID-19 Treatment Cuts Recovery Time, Chance of Severe Cases

Celltrion Says its COVID-19 Treatment Cuts Recovery Time, Chance of Severe Cases

SEOUL, Jan. 13 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. said Wednesday that its COVID-19 treatment candidate reduces recovery time and the chance of a severe case developing. It was making public clinical data on the second-phase global trial study of the CT-P59, an anti-COVID-19 monoclonal antibody treatment candidate. The firm earlier submitted [...]

Celltrion’s COVID-19 Treatment Shows Higher Efficacy than 2 Rivals

Celltrion’s COVID-19 Treatment Shows Higher Efficacy than 2 Rivals

SEOUL, Jan. 12 (Korea Bizwire) — South Korea’s pharmaceutical giant Celltrion Inc. said Tuesday that its anti-COVID-19 monoclonal antibody treatment has shown higher treatment efficacy compared to its two rival candidates. The Korean Ministry of Food and Drug Safety is currently reviewing conditional approval of Celltrion’s CT-P59, also known as Regdanvimab, a move that could [...]

Daewoong Pharmaceutical Eyes COVID-19 Treatment’s Launch Early Next Year

Daewoong Pharmaceutical Eyes COVID-19 Treatment’s Launch Early Next Year

SEOUL, Dec. 21 (Korea Bizwire) — South Korean drugmaker maker Daewoong Pharmaceutical Co. aims to launch a treatment drug for the novel coronavirus early next year, the company’s chief said Monday. Foistar, an oral protease inhibitor, is currently undergoing phase two clinical trial on COVID-19 patients with mild symptoms. The company aims to release the [...]

Celltrion Eyes Emergency Authorization for COVID-19 Treatment Next Month

Celltrion Eyes Emergency Authorization for COVID-19 Treatment Next Month

SEOUL, Nov. 18 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc.’s coronavirus treatment is likely to file for emergency authorization use from local drug authorities next month, the company’s chief said Wednesday. CT-P59, anti-COVID-19 monoclonal antibody treatment, is currently undergoing a phase two clinical trial locally after successfully completing a phase one clinical trial [...]

Celltrion’s COVID-19 Treatment Kills Virus Within 4-5 Days: Chief

Celltrion’s COVID-19 Treatment Kills Virus Within 4-5 Days: Chief

SEOUL, Nov. 11 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc.’s COVID-19 treatment kills the coronavirus within 4-5 days, effectively protecting patients with mild symptoms from developing a severe case, the company’s chief said Wednesday. Celltrion Group Chairman Seo Jung-jin said the first stage trial of CT-P59, anti-COVID-19 monoclonal antibody treatment, shortened the recovery [...]

S. Korean Researchers Succeed in Animal Test for COVID-19 Treatment

S. Korean Researchers Succeed in Animal Test for COVID-19 Treatment

SEOUL, Aug. 6 (Korea Bizwire) — A state-run research institute with a specialty in weapons development is now developing a cure for COVID-19. South Korea’s Agency for Defense Development (ADD) announced on Wednesday that it confirmed the effectiveness of its newly-developed COVID-19 siRNA gene therapy treatment after conducting animal tests. The new treatment is designed [...]

Algernon Announces Enrollment of First Patient in 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

Algernon Announces Enrollment of First Patient in 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

VANCOUVER, British Columbia, Aug. 5 (Korea Bizwire) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has enrolled its first patient in its multinational Phase 2b/3 human study of NP-120 (Ifenprodil) for the treatment of COVID-19. The countries participating in [...]